DongKoo Bio & Pharma to Cancel 822,134 Treasury Shares
Bitget2026/10/28 02:48- DongKoo Bio & Pharma resolved on October 28, 2026, to cancel 822,134 previously acquired common shares.
- The cancellation will reduce outstanding common shares from 28,464,992 to 27,642,858 without reducing capital.
- The shares have a book value of KRW 3 billion and a par value of KRW 500 each.
- The treasury-share acquisition trust agreement dated July 22, 2026, was terminated on October 28, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
